Skip to main content
. 2019 Feb 12;111(10):1033–1041. doi: 10.1093/jnci/djy230

Figure 7.

Figure 7.

Targeting NRF2 antioxidant pathway for IDH1-mutated cancers. IDHWT cells exhibit normal reactive oxygen species (ROS) burden. NRF2 is recognized by KEAP1 and constitutively removed through proteasomal degradation. In IDH1R132H cells, elevated ROS burden leads to NRF2 stabilization, nuclear translocation, and transcriptional activation of antioxidant genes. NRF2 downstream genes not only assist ROS homeostasis in IDH1-mutated cancer but also serve as potential resistance mechanism for chemotherapies.